Skip to main content
Top
Published in: Esophagus 3/2021

Open Access 01-07-2021 | Esophagus Resection | Original Article

Feasibility and effectiveness of multi-injection thoracic paravertebral block via the intrathoracic approach for analgesia after thoracoscopic-laparoscopic esophagectomy

Authors: Lihong Hu, Xia Xu, Weiyu Shen, Jinxian He

Published in: Esophagus | Issue 3/2021

Login to get access

Abstract

Background

We observed the feasibility and effectiveness of multi-injection thoracic paravertebral block (TPB) via the intrathoracic approach under thoracoscopic direct vision for analgesia after thoracoscopic-laparoscopic esophagectomy (TLE).

Methods

Sixty patients undergoing TLE were randomly divided into a control group and an observation group. All patients underwent TPB via the intrathoracic approach at the three levels of T2, 5, and 8 with a scalp needle before closing the chest. The patients in the observation group received 10 ml 0.375% ropivacaine at each level, and the patients in the control group received 10 ml of 0.9% saline at each level. A patient-controlled intravenous analgesic (PCIA) pump with sufentanil was attached to all patients after surgery. The sufentanil consumption, number of PCIA presses and use of rescue analgesia in the first 24 h after surgery were recorded. The visual analogue scale (VAS) scores (rest and coughing) were recorded at 2 h, 6 h, 12 h, 24 h, and 48 h after surgery. The duration of postoperative hospital stay, active cough rate, first ambulation, and the incidence of adverse reactions after surgery was recorded.

Results

The sufentanil consumption in the observation group was significantly lower than that in the control group (34.7 ± 1.9 µg vs. 52.1 ± 2.1 µg; P < 0.001). The VAS score at each postoperative time point, number of PCIA presses, use of rescue analgesia, and the incidence of adverse reactions in the observation group were significantly lower than those in the control group. The postoperative active cough rate of patients in the observation group was significantly higher than those in the control group, and the times of the first ambulation after surgery and postoperative hospital stay in the observation group were significantly shorter than those in the control group (all P < 0.05).

Conclusions

Multi-injection TPB via the intrathoracic approach under thoracoscopic direct vision is easy to perform and can effectively alleviate postoperative pain after TLE with fewer adverse reactions and contributing to improved postoperative recovery.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lin Y, Totsuka Y, Shan B, et al. Esophageal cancer in high-risk areas of China: research progress and challenges. Ann Epidemiol. 2017;27(3):215–21.CrossRef Lin Y, Totsuka Y, Shan B, et al. Esophageal cancer in high-risk areas of China: research progress and challenges. Ann Epidemiol. 2017;27(3):215–21.CrossRef
2.
go back to reference Kauppila JH, Wahlin K, Lagergren P, et al. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma. Int J Cancer. 2019;144(6):1284–91.CrossRef Kauppila JH, Wahlin K, Lagergren P, et al. Sex differences in the prognosis after surgery for esophageal squamous cell carcinoma and adenocarcinoma. Int J Cancer. 2019;144(6):1284–91.CrossRef
3.
go back to reference Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260(2):259–66.CrossRef Takeuchi H, Miyata H, Gotoh M, et al. A risk model for esophagectomy using data of 5354 patients included in a Japanese nationwide web-based database. Ann Surg. 2014;260(2):259–66.CrossRef
4.
go back to reference Sihag S, Kosinski AS, Gaissert HA, et al. Minimally invasive versus open esophagectomy for esophageal cancer: a comparison of early surgical outcomes from the society of thoracic surgeons national database. Ann Thorac Surg. 2016;101(4):1281–9.CrossRef Sihag S, Kosinski AS, Gaissert HA, et al. Minimally invasive versus open esophagectomy for esophageal cancer: a comparison of early surgical outcomes from the society of thoracic surgeons national database. Ann Thorac Surg. 2016;101(4):1281–9.CrossRef
5.
go back to reference Straatman J, van der Wielen N, Cuesta MA, et al. Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME trial. Ann Surg. 2017;266(2):232–6.CrossRef Straatman J, van der Wielen N, Cuesta MA, et al. Minimally invasive versus open esophageal resection: three-year follow-up of the previously reported randomized controlled trial: the TIME trial. Ann Surg. 2017;266(2):232–6.CrossRef
7.
go back to reference van den Berg JW, Tabrett K, Cheong E. Paravertebral catheter analgesia for minimally invasive Ivor Lewis oesophagectomy. J Thoracic Dis. 2019;11(Suppl 5):S786–93.CrossRef van den Berg JW, Tabrett K, Cheong E. Paravertebral catheter analgesia for minimally invasive Ivor Lewis oesophagectomy. J Thoracic Dis. 2019;11(Suppl 5):S786–93.CrossRef
8.
go back to reference Hu LH, Xu X, Shen WY, et al. Application of thoracoscopy-guided thoracic paravertebral block for analgesia after single-port video-assisted pulmonary lobectomy. Nat Med J China. 2020;100(33):2596–600. Hu LH, Xu X, Shen WY, et al. Application of thoracoscopy-guided thoracic paravertebral block for analgesia after single-port video-assisted pulmonary lobectomy. Nat Med J China. 2020;100(33):2596–600.
9.
go back to reference Niwa Y, Koike M, Torii K, et al. Combination of continuous paravertebral block and epidural anesthesia in postoperative pain control after esophagectomy. Esophagus. 2016;13:42–7.CrossRef Niwa Y, Koike M, Torii K, et al. Combination of continuous paravertebral block and epidural anesthesia in postoperative pain control after esophagectomy. Esophagus. 2016;13:42–7.CrossRef
10.
go back to reference Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.CrossRef Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–32.CrossRef
11.
go back to reference Poupore AK, Stem M, Molena D, et al. Incidence, reasons, and risk factors for read mission after surgery for benign distal esophageal disease. Surgery. 2016;160(3):599–606.CrossRef Poupore AK, Stem M, Molena D, et al. Incidence, reasons, and risk factors for read mission after surgery for benign distal esophageal disease. Surgery. 2016;160(3):599–606.CrossRef
12.
go back to reference Kauppila JH, Xie S, Johar A, et al. Meta-analysis of health-related quality of life after minimallyinvasive versus open oesophagectomy for oesophageal cancer. Br J Surg. 2017;104(9):1131–40.CrossRef Kauppila JH, Xie S, Johar A, et al. Meta-analysis of health-related quality of life after minimallyinvasive versus open oesophagectomy for oesophageal cancer. Br J Surg. 2017;104(9):1131–40.CrossRef
13.
go back to reference Weijs TJ, Ruurda JP, Nieuwenhuijzen GA, et al. Strategies to reduce pulmonary complications after esophagectomy. World J Gastroenterol. 2013;19:6509–14.CrossRef Weijs TJ, Ruurda JP, Nieuwenhuijzen GA, et al. Strategies to reduce pulmonary complications after esophagectomy. World J Gastroenterol. 2013;19:6509–14.CrossRef
14.
go back to reference Seesing MFJ, Borggreve AS, Ruurda JP, et al. New-onset atrial fibrillation after esophagectomy for cancer. J Toracic Dis. 2019;11(S5):S831–4.CrossRef Seesing MFJ, Borggreve AS, Ruurda JP, et al. New-onset atrial fibrillation after esophagectomy for cancer. J Toracic Dis. 2019;11(S5):S831–4.CrossRef
15.
go back to reference Low DE, Allum W, De Manzoni G, et al. Guidelines for perioperative care in esophagectomy: enhanced recovery after surgery (ERAS) society recommendations. World J Surg. 2019;43:299–330.CrossRef Low DE, Allum W, De Manzoni G, et al. Guidelines for perioperative care in esophagectomy: enhanced recovery after surgery (ERAS) society recommendations. World J Surg. 2019;43:299–330.CrossRef
16.
go back to reference Guo W, Ma X, Yang S, et al. Combined thoracoscopic-laparscopic esophagectomy versus open esophagectomy: a meta-analysis of outcomes. Surg Endosc. 2016;30(9):3873–81.CrossRef Guo W, Ma X, Yang S, et al. Combined thoracoscopic-laparscopic esophagectomy versus open esophagectomy: a meta-analysis of outcomes. Surg Endosc. 2016;30(9):3873–81.CrossRef
17.
go back to reference Durkin C, Schisler T, Lohser J. Current trends in anesthesia for esophagectomy. Curr Opin Anaesthesiol. 2017;30:30–5.CrossRef Durkin C, Schisler T, Lohser J. Current trends in anesthesia for esophagectomy. Curr Opin Anaesthesiol. 2017;30:30–5.CrossRef
18.
go back to reference Wei K, Min S, Hao Y, et al. Postoperative analgesia after combined thoracoscopic-laparoscopic esophagectomy: a randomized comparison of continuous infusion and intermittent bolus thoracic epidural regimens. J Pain Res. 2019;12:29–37.CrossRef Wei K, Min S, Hao Y, et al. Postoperative analgesia after combined thoracoscopic-laparoscopic esophagectomy: a randomized comparison of continuous infusion and intermittent bolus thoracic epidural regimens. J Pain Res. 2019;12:29–37.CrossRef
19.
go back to reference Hermanides J, Hollmann MW, Stevens MF, et al. Failed epidural: causes and management. Br J Anaesth. 2012;109:144–54.CrossRef Hermanides J, Hollmann MW, Stevens MF, et al. Failed epidural: causes and management. Br J Anaesth. 2012;109:144–54.CrossRef
20.
go back to reference Christie IW, McCabe S. Major complications of epidural analgesia after surgery: results of a six-year survey. Anaesthesia. 2007;62:335–41.CrossRef Christie IW, McCabe S. Major complications of epidural analgesia after surgery: results of a six-year survey. Anaesthesia. 2007;62:335–41.CrossRef
21.
go back to reference Al-Rawi OY, Pennefather SH, Page RD, et al. The effect of thoracic epidural bupivacaine and an intravenous adrenaline infusion on gastric tube blood flow during esophagectomy. Anesth Analg. 2008;106:884–7.CrossRef Al-Rawi OY, Pennefather SH, Page RD, et al. The effect of thoracic epidural bupivacaine and an intravenous adrenaline infusion on gastric tube blood flow during esophagectomy. Anesth Analg. 2008;106:884–7.CrossRef
22.
go back to reference Tang CL, Hu YD, Zhang ZT, et al. Dexmedetomidine with sufentanil in intravenous patient-controlled analgesia for relief from postoperative pain, inflammation and delirium after esophageal cancer surgery. Biosci Rep. 2020;40(5):BSR20193410.CrossRef Tang CL, Hu YD, Zhang ZT, et al. Dexmedetomidine with sufentanil in intravenous patient-controlled analgesia for relief from postoperative pain, inflammation and delirium after esophageal cancer surgery. Biosci Rep. 2020;40(5):BSR20193410.CrossRef
23.
go back to reference Katz P, Takyar S, Palmer P, et al. Sublingual, transdermal and intravenous patient-controlled analgesia for acute post-operative pain: systematic literature review and mixed treatment comparison. Curr Med Res Opin. 2017;33(5):899–910.CrossRef Katz P, Takyar S, Palmer P, et al. Sublingual, transdermal and intravenous patient-controlled analgesia for acute post-operative pain: systematic literature review and mixed treatment comparison. Curr Med Res Opin. 2017;33(5):899–910.CrossRef
24.
go back to reference Mowat I, Schneider F, GhorI A. Paravertebral blockade in thoracoscopic surgery. Eur J Cardiothorac Surg. 2012;42(2):390.CrossRef Mowat I, Schneider F, GhorI A. Paravertebral blockade in thoracoscopic surgery. Eur J Cardiothorac Surg. 2012;42(2):390.CrossRef
25.
go back to reference Yeung JH, Gates S, Naidu BV, et al. Paravertebral block versus thoracic epidural for patients undergoing thoracotomy. Cochrane Database Syst Rev. 2016;2:CD009121.PubMed Yeung JH, Gates S, Naidu BV, et al. Paravertebral block versus thoracic epidural for patients undergoing thoracotomy. Cochrane Database Syst Rev. 2016;2:CD009121.PubMed
27.
go back to reference Kingma BF, Eshuis WJ, de Groot EM, et al. Paravertebral catheter versus epidural analgesia in minimally invasive esophageal resection: a randomized controlled multicenter trial (PEPMEN trial). BMC Cancer. 2020;20(1):142.CrossRef Kingma BF, Eshuis WJ, de Groot EM, et al. Paravertebral catheter versus epidural analgesia in minimally invasive esophageal resection: a randomized controlled multicenter trial (PEPMEN trial). BMC Cancer. 2020;20(1):142.CrossRef
28.
go back to reference Zhang W, Fang C, Li J, et al. Single-dose, bilateral paravertebral block plus intravenous sufentanil analgesia in patients with esophageal cancer undergoing combined thoracoscopic-laparoscopic esophagectomy: a safe and effective alternative. J Cardiothorac Vasc Anesth. 2014;28(4):978–84.CrossRef Zhang W, Fang C, Li J, et al. Single-dose, bilateral paravertebral block plus intravenous sufentanil analgesia in patients with esophageal cancer undergoing combined thoracoscopic-laparoscopic esophagectomy: a safe and effective alternative. J Cardiothorac Vasc Anesth. 2014;28(4):978–84.CrossRef
Metadata
Title
Feasibility and effectiveness of multi-injection thoracic paravertebral block via the intrathoracic approach for analgesia after thoracoscopic-laparoscopic esophagectomy
Authors
Lihong Hu
Xia Xu
Weiyu Shen
Jinxian He
Publication date
01-07-2021
Publisher
Springer Singapore
Published in
Esophagus / Issue 3/2021
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-020-00807-9

Other articles of this Issue 3/2021

Esophagus 3/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine